APA (7th ed.) Citation

P, L., PO, B., V, C., T, S., V, M., L, A., . . . H, W. (2025). Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta. Liver international : official journal of the International Association for the Study of the Liver, 45(2), e70008. https://doi.org/10.1111/liv.70008

Chicago Style (17th ed.) Citation

P, Lampertico, et al. "Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta." Liver International : Official Journal of the International Association for the Study of the Liver 45, no. 2 (2025): e70008. https://doi.org/10.1111/liv.70008.

MLA (9th ed.) Citation

P, Lampertico, et al. "Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta." Liver International : Official Journal of the International Association for the Study of the Liver, vol. 45, no. 2, 2025, p. e70008, https://doi.org/10.1111/liv.70008.